LSTA Stock Price | Lisata Therapeutics Inc. P/E, Revenue, EPS, & Forecasts

Lisata Therapeutics Inc. • LSTA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Lisata Therapeutics Inc.

Ticker

LSTA

Trading on

NASDAQ

ISIN

US1280583022

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.

Headquarters

110 Allen Road, Basking Ridge, NJ, United States, 07920

Employees

Website

lisata.com

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Metrics

BasicAdvanced

Market cap

$17M

P/E ratio

EPS

-$2.13

Dividend Yield

0.00%

Beta

1.07

Forward P/E ratio

EBIDTA

$-19.9M

Ex dividend date

Price & volume

Market cap

$17M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

15.87

Price to book

Earnings

EPS

-$2.13

EPS estimate (current quarter)

-$0.54

EPS estimate (next quarter)

-$0.62

EBITDA

$-19.9M

Revenues (TTM)

$1.1M

Revenues per share (TTM)

$0.13

Technicals

Beta

1.07

52-week High

$4.20

52-week Low

$1.81

50-day moving average

$2.34

200-day moving average

$2.41

Short ratio

0.17

Short %

0.29%

Management effectiveness

ROE (TTM)

-72.17%

ROA (TTM)

-41.86%

Profit margin

0.00%

Gross profit margin

$1.1M

Operating margin

-1,876.54%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

8.8M

Float

7.3M

Insiders %

19.68%

Institutions %

8.38%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 3 analysts.

Average price target

$13.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.55

-$0.76

27.63%

Q4 • 24Beat

-$0.55

-$0.53

-3.77%

Q1 • 25Missed

-$0.54

-$0.64

15.63%

Q2 • 25Beat

-$0.49

-$0.59

16.95%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.1M

$-4.7M

-6,655.71%

Q2 • 25

$0M

$-4.2M

-∞%

Q3 • 25

-100.00%

-8.80%

∞%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$25.2M

$4.4M

17.43%

Q2 • 25

$21.8M

$4.6M

21.32%

Q3 • 25

-13.52%

5.82%

22.35%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-4M

$0.5M

$0.1M

$-4M

Q2 • 25

$-3.3M

$5.2M

$0.4M

$-3.3M

Q3 • 25

-15.52%

919.80%

451.56%

-16.11%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Lisata Therapeutics Inc. share?

Lisata Therapeutics Inc. shares are currently traded for undefined per share.

How many shares does Lisata Therapeutics Inc. have?

Lisata Therapeutics Inc. currently has 8.8M shares.

Does Lisata Therapeutics Inc. pay dividends?

No, Lisata Therapeutics Inc. doesn't pay dividends.

What is Lisata Therapeutics Inc. 52 week high?

Lisata Therapeutics Inc. 52 week high is $4.20.

What is Lisata Therapeutics Inc. 52 week low?

Lisata Therapeutics Inc. 52 week low is $1.81.

What is the 200-day moving average of Lisata Therapeutics Inc.?

Lisata Therapeutics Inc. 200-day moving average is $2.41.

Who is Lisata Therapeutics Inc. CEO?

The CEO of Lisata Therapeutics Inc. is Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D..

How many employees Lisata Therapeutics Inc. has?

Lisata Therapeutics Inc. has 26 employees.

What is the market cap of Lisata Therapeutics Inc.?

The market cap of Lisata Therapeutics Inc. is $17M.

What is the P/E of Lisata Therapeutics Inc.?

The current P/E of Lisata Therapeutics Inc. is null.

What is the EPS of Lisata Therapeutics Inc.?

The EPS of Lisata Therapeutics Inc. is -$2.13.

What is the PEG Ratio of Lisata Therapeutics Inc.?

The PEG Ratio of Lisata Therapeutics Inc. is null.

What do analysts say about Lisata Therapeutics Inc.?

According to the analysts Lisata Therapeutics Inc. is considered a buy.